A multinational,randomized, placebo-controlled trial to assess the immunogenicity,safety, and tolerability of live attenuated influenza vaccine coadministered with oral poliovirus vaccine in healthy young children |
| |
Authors: | Robert F. Breiman,W. Abdullah Brooks,Doli Goswami,Rosanna Lagos,Charissa Borja-Tabora,Claudio F. Lanata,Jaime A. Cè spedes Londoñ o,Lucy Chai See Lum,Ruth Rappaport,Ahmad Razmpour,Robert E. Walker,William C. Gruber,Bruce D. Forrest |
| |
Affiliation: | 1. Programme on Infectious Diseases and Vaccine Sciences, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh;2. Hospital de Niños Roberto del Rio Centro Para Vacunas En Desarrollo-Chile, Santiago, Chile;3. Manila Doctors Hospital, Manila, Philippines;4. Instituto de Investigacion Nutricional, Lima, Peru;5. Fundación CardioInfantil, Bogota, Colombia;6. Department of Pediatrics, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia;g Wyeth Vaccines Research, Pearl River, NY, United States;h MedImmune, Gaithersburg, MD, United States |
| |
Abstract: | Live attenuated influenza vaccine (LAIV) provides a useful tool to rapidly immunize populations in the developing world to prevent influenza outbreaks. In this noninferiority trial conducted in Asia and South America, where oral poliovirus vaccine (OPV) is still used, 2503 children aged 6 to <36 months with three polio immunizations were randomized to receive LAIV + OPV, placebo + OPV, or LAIV only. Immune responses in children receiving concomitant LAIV + OPV were noninferior to those observed in recipients of either vaccine alone. Response rates for different poliovirus types were similar in recipients of LAIV + OPV and placebo + OPV. Response rates to all influenza strains were similar in LAIV + OPV and LAIV-only recipients. Concomitant OPV and LAIV were safely administered to young children. |
| |
Keywords: | Children Live attenuated influenza vaccine Oral poliovirus vaccine |
本文献已被 ScienceDirect 等数据库收录! |
|